A patient survived for a record nine months using a genetically modified pig kidney before successfully receiving a human kidney transplant on September 4, 2026.
This medical milestone, documented by researchers, demonstrates the potential for xenotransplantation to serve as a bridge for patients awaiting human organ donors.
The success of this procedure provides critical data for future clinical trials aimed at addressing the global shortage of transplantable human organs.